Literature DB >> 16092115

Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma.

Peter Choi1, Chu Chen.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) is associated with considerable mortality and morbidity and is a major public health concern worldwide. To date, > 20 studies incorporating DNA microarray analyses have examined genomewide genetic expression changes associated with the development of HNSCC. The authors identified published reports of genetic expression profiles of HNSCC by Medline database search. They performed a review of the reports to identify genes that have been found repeatedly to exhibit substantially altered expression in HNSCC. Genes with altered expression were subsequently examined in the context of defined biologic systems with the use of GenMapp 2.0 pathway analysis software. Genes most commonly found to exhibit altered expression were those encoding for cytoskeletal and extracellular matrix proteins, inflammatory mediators, proteins involved in epidermal differentiation, and cell adhesion molecules. Results of GenMapp 2.0 analysis suggested global down-regulation of genes that encode for ribosomal proteins and enzymes in the cholesterol biosynthesis pathway; and up-regulation of genes that encode for matrix metalloproteinases and genes that bear on the inflammatory response. The review indicated that there are several genes and pathways that exhibit substantially altered expression in cancerous versus noncancerous states across studies. Further investigation into the genomic, proteomic, and functional consequences of these gene expression alterations may provide insight into the pathophysiology of HNSCC. Copyright 2005 American Cancer Society.

Entities:  

Mesh:

Year:  2005        PMID: 16092115     DOI: 10.1002/cncr.21293

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  38 in total

Review 1.  Molecular biology of squamous cell carcinoma of the head and neck.

Authors:  B Perez-Ordoñez; M Beauchemin; R C K Jordan
Journal:  J Clin Pathol       Date:  2006-05       Impact factor: 3.411

2.  Site-specific molecular signatures predict aggressive disease in HNSCC.

Authors:  Thomas J Belbin; Nicolas F Schlecht; Richard V Smith; Leslie R Adrien; Nicole Kawachi; Margaret Brandwein-Gensler; Aviv Bergman; Quan Chen; Geoffrey Childs; Michael B Prystowsky
Journal:  Head Neck Pathol       Date:  2008-08-02

3.  Gene expression profiling identifies genes predictive of oral squamous cell carcinoma.

Authors:  Chu Chen; Eduardo Méndez; John Houck; Wenhong Fan; Pawadee Lohavanichbutr; Dave Doody; Bevan Yueh; Neal D Futran; Melissa Upton; D Gregory Farwell; Stephen M Schwartz; Lue Ping Zhao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07-31       Impact factor: 4.254

4.  Metal-proteinase ADAM12, kinesin 14 and checkpoint suppressor 1 as new molecular markers of laryngeal carcinoma.

Authors:  Jarosław Markowski; Tomasz Tyszkiewicz; Michał Jarzab; Małgorzata Oczko-Wojciechowska; Tatiana Gierek; Małgorzata Witkowska; Jarosław Paluch; Małgorzata Kowalska; Zbigniew Wygoda; Dariusz Lange; Barbara Jarzab
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-16       Impact factor: 2.503

5.  The Role of the NF-kappaB Transcriptome and Proteome as Biomarkers in Human Head and Neck Squamous Cell Carcinomas.

Authors:  Zhong Chen; Bin Yan; Carter Van Waes
Journal:  Biomark Med       Date:  2008       Impact factor: 2.851

6.  Biodistribution Study of Nanoparticle Encapsulated Photodynamic Therapy Drugs Using Multispectral Imaging.

Authors:  Luma V Halig; Dongsheng Wang; Andrew Y Wang; Zhuo Georgia Chen; Baowei Fei
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2013-03-29

7.  A prototype tobacco-associated oral squamous cell carcinoma classifier using RNA from brush cytology.

Authors:  Antonia Kolokythas; Mitchell J Bosman; Kristen B Pytynia; Suchismita Panda; Herve Y Sroussi; Yang Dai; Joel L Schwartz; Guy R Adami
Journal:  J Oral Pathol Med       Date:  2013-04-17       Impact factor: 4.253

Review 8.  Current status of pharmacogenomics testing for anti-tumor drug therapies: approaches to non-melanoma skin cancer.

Authors:  Rebecca Grealy; Lyn R Griffiths
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

9.  Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse.

Authors:  Benjamin Lallemant; Alexandre Evrard; Christophe Combescure; Heliette Chapuis; Guillaume Chambon; Caroline Raynal; Christophe Reynaud; Omar Sabra; Dominique Joubert; Frédéric Hollande; Jean-Gabriel Lallemant; Serge Lumbroso; Jean-Paul Brouillet
Journal:  BMC Cancer       Date:  2009-10-18       Impact factor: 4.430

10.  Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene.

Authors:  F M Buffa; A L Harris; C M West; C J Miller
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.